Terug
Dagbereik
€ 5,28
€ 5,51
52-Weeksbereik
€ 3,21
€ 8,40
Volume
3.830.071
50D / 200D Gem.
€ 6,82
/
€ 5,67
Vorige Slotkoers
€ 5,31
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,1 | 0,4 |
| P/B | 7,8 | 2,9 |
| ROE % | -36,2 | 3,7 |
| Net Margin % | -15,1 | 3,8 |
| Rev Growth 5Y % | 152,0 | 10,0 |
| D/E | 1,3 | 0,2 |
Belangrijkste Punten
Revenue grew 152,02% annually over 5 years — strong growth
Negative free cash flow of -43,98M
Revenue growth is decelerating — 1Y growth trails 5Y average by 129,93%
Capital efficient — spends only 0,37% of revenue on capex
Groei
Revenue Growth (5Y)
152,02%
Revenue (1Y)22,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-36,21%
ROIC-8,12%
Net Margin-15,12%
Op. Margin-10,06%
Veiligheid
Debt / Equity
1,27
Current Ratio4,31
Interest Coverage-1,44
Waardering
P/E Ratio
-21,14
P/B Ratio7,80
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,09% | Revenue Growth (3Y) | 80,91% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 152,02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 407,32M | Net Income (TTM) | -61,60M |
| ROE | -36,21% | ROA | -12,28% |
| Gross Margin | 90,29% | Operating Margin | -10,06% |
| Net Margin | -15,12% | Free Cash Flow (TTM) | -43,98M |
| ROIC | -8,12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,27 | Current Ratio | 4,31 |
| Interest Coverage | -1,44 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,14 | P/B Ratio | 7,80 |
| P/S Ratio | 3,20 | PEG Ratio | -0,43 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,30B | Enterprise Value | 1,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 407,32M | 333,62M | 124,46M | 52,16M | 10,10M |
| Net Income | -61,60M | -39,14M | -66,07M | -67,21M | -158,17M |
| EPS (Diluted) | -0,26 | -0,17 | -0,30 | -0,42 | -1,52 |
| Gross Profit | 367,78M | 283,06M | 106,66M | 48,04M | 9,10M |
| Operating Income | -40,98M | -27,95M | -63,28M | -63,76M | -154,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 501,60M | 435,75M | 297,58M | 190,07M | 149,91M |
| Total Liabilities | 334,66M | 262,47M | 130,76M | 91,74M | 67,30M |
| Shareholders' Equity | 166,95M | 173,29M | 166,82M | 98,33M | 82,62M |
| Total Debt | 211,60M | 153,44M | 55,98M | 36,46M | 45,50M |
| Cash & Equivalents | 68,00M | 64,93M | 21,47M | 96,14M | 72,43M |
| Current Assets | 382,32M | 356,45M | 246,11M | 153,60M | 133,65M |
| Current Liabilities | 88,61M | 77,83M | 50,39M | 65,60M | 52,82M |